Patients in the US with newly diagnosed GCA face excessive delays to initiating subcutaneous TCZ, as well high out-of-pocket costs.

VIVEX Biologics, Inc. sponsored research reports positive outcomes for patients with chronic lumbar discogenic pain treated ...

Subcutaneous administration generally safe and well-tolerated across multiple doses>80% reduction in anti-VEGF intravitreal injection burden in wet AMD and DME study eyes and >75% total reduction in ...

The FDA approved the use of daratumumab and hyaluronidase-fihj (Darzalex Faspro) for patients who are newly diagnosed with ...

The subcutaneous formulation of daratumumab makes treatment a faster and more tolerable process for patients with multiple ...

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDPFirst novel mechanism of action for CIDP treatment in more than 30 yearsCHMP positive opinion based on ADHERE data, the largest ...

Under the Surface of Subcutaneous Adipose Tissue Biology. Acta Dermatovenerol Croat. 2016;24(4):250-260. Derraik JG, Rademaker M, Cutfield WS, et al. Effects of age, gender, BMI, and anatomical site ...

Repatha (evolocumab) is a brand-name subcutaneous injection that isn’t known to interact with alcohol, other drugs, or supplements. However, Repatha has health-related interactions that are ...

Two years ago, Healey announced her support for the idea of supervised drug-use sites, also known as safe injection sites. It is illegal and Trump would never allow it. Last year, the Massachusetts ...

The Vyvgart Hytrulo prefilled syringe is approved as a 20- to 30-second subcutaneous injection administered by a patient, caregiver, or health care professional. The approval is based on studies ...

The 12–month study involved 233 subjects, including 217 patients under the age of 18. Only 14% of the patients who received subcutaneous injections of immunoglobulin missed work or study due to ...